Impact of Age-3 Urine Screening on Diagnosis and Treatment Timing in Alport Syndrome. [PDF]
Kitakado H +11 more
europepmc +1 more source
A Western Diet High in Phosphate Primes the Development of the CKD-Mineral Bone Disorder in an Alport Syndrome Model. [PDF]
Williams MJ +5 more
europepmc +1 more source
An Elusive Diagnosis of Autosomal Dominant Alport Syndrome: Genomic Sequencing Is a Game Changer. [PDF]
Betsikos A +4 more
europepmc +1 more source
Bilateral Macular Holes with Depleted Internal Limiting Membrane in Alport Syndrome Patient: A Case Report. [PDF]
Suh YK, Bae K, Park UC.
europepmc +1 more source
From RAAS blockade to regenerative medicine: evolving treatment strategies in Alport syndrome. [PDF]
Lo Re C, Kim JJ, Fornoni A.
europepmc +1 more source
A Novel Homozygous <i>COL4A3</i> c.1873G>A (p.Gly625Ser) Variant Presenting With Autosomal Recessive Alport Syndrome: Clinical, Genetic, and Segregation Evidence. [PDF]
Ural Z, Derici Ü.
europepmc +1 more source
Systematic metabolomic study on the plasma and urine of a mouse model of Alport syndrome. [PDF]
Choi HS +9 more
europepmc +1 more source
Modulation of the Apolipoprotein M/S1PR4 Pathway Reduces Podocyte Lipid Overload in Alport Syndrome via Distinct Autophagy and Efflux Mechanisms. [PDF]
Tolerico M +14 more
europepmc +1 more source
Dapagliflozin, in addition to ramipril, ameliorates kidney disease progression in mice with Alport syndrome. [PDF]
Miyata KN +11 more
europepmc +1 more source

